BE898356A - Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine. - Google Patents

Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine. Download PDF

Info

Publication number
BE898356A
BE898356A BE1/10914A BE1010914A BE898356A BE 898356 A BE898356 A BE 898356A BE 1/10914 A BE1/10914 A BE 1/10914A BE 1010914 A BE1010914 A BE 1010914A BE 898356 A BE898356 A BE 898356A
Authority
BE
Belgium
Prior art keywords
component
composition according
sep
pharmaceutically acceptable
molecular weight
Prior art date
Application number
BE1/10914A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE898356A publication Critical patent/BE898356A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE1/10914A 1982-12-10 1983-12-02 Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine. BE898356A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (1)

Publication Number Publication Date
BE898356A true BE898356A (fr) 1984-06-04

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10914A BE898356A (fr) 1982-12-10 1983-12-02 Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine.

Country Status (25)

Country Link
JP (1) JPH0672101B2 (show.php)
AT (1) AT382514B (show.php)
AU (1) AU570658B2 (show.php)
BE (1) BE898356A (show.php)
CA (1) CA1224416A (show.php)
CH (1) CH656533A5 (show.php)
CY (1) CY1509A (show.php)
DD (1) DD215469B3 (show.php)
DK (1) DK162475C (show.php)
FR (1) FR2537435B1 (show.php)
GB (1) GB2131691B (show.php)
GR (1) GR79745B (show.php)
HK (1) HK23290A (show.php)
HU (1) HU190513B (show.php)
IE (1) IE56366B1 (show.php)
IL (1) IL70406A (show.php)
IT (1) IT1172368B (show.php)
LU (1) LU85127A1 (show.php)
NL (1) NL8304221A (show.php)
NZ (1) NZ206523A (show.php)
PH (1) PH23451A (show.php)
PT (1) PT77803B (show.php)
SE (1) SE468973B (show.php)
SG (1) SG53989G (show.php)
ZA (1) ZA839200B (show.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792L (sv) 1984-06-11
FR2537435B1 (fr) 1987-03-20
SG53989G (en) 1989-12-29
IL70406A0 (en) 1984-03-30
HU190513B (en) 1986-09-29
DD215469B3 (de) 1988-03-09
AT382514B (de) 1987-03-10
CH656533A5 (de) 1986-07-15
IT8349456A1 (it) 1985-06-07
PT77803A (en) 1984-01-01
LU85127A1 (fr) 1984-10-22
DK162475B (da) 1991-11-04
PH23451A (en) 1989-08-07
GB2131691B (en) 1986-12-03
JPH0672101B2 (ja) 1994-09-14
IT1172368B (it) 1987-06-18
SE468973B (sv) 1993-04-26
AU2222183A (en) 1984-06-14
AU570658B2 (en) 1988-03-24
ATA428483A (de) 1986-08-15
NL8304221A (nl) 1984-07-02
ZA839200B (en) 1985-07-31
CY1509A (en) 1990-08-03
DK565783A (da) 1984-06-11
DD215469A5 (de) 1984-11-14
GB8332653D0 (en) 1984-01-11
HUT34124A (en) 1985-02-28
HK23290A (en) 1990-04-06
CA1224416A (en) 1987-07-21
DK565783D0 (da) 1983-12-08
FR2537435A1 (fr) 1984-06-15
IE832896L (en) 1984-06-10
GR79745B (show.php) 1984-10-31
NZ206523A (en) 1987-04-30
IE56366B1 (en) 1991-07-03
JPS59116222A (ja) 1984-07-05
DK162475C (da) 1992-05-11
IT8349456A0 (it) 1983-12-07
IL70406A (en) 1988-08-31
GB2131691A (en) 1984-06-27
SE8306792D0 (sv) 1983-12-08
PT77803B (en) 1986-04-17

Similar Documents

Publication Publication Date Title
CA2233924C (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP1968711B2 (fr) Gel viscoelastique a usage dermatologique
FR2670487A1 (fr) Nouveau sel de 3-[2-dimethylamino)ethyl-]-n-methyl-1h-indole-5-methanesulfonamide, sa preparation et son utilisation comme medicament.
FR2547727A1 (fr) Compositions pharmaceutiques
BE1003647A5 (fr) Composition pharmaceutique de nicardipine pour administration parenterale.
LU87513A1 (fr) Procede pour ameliorer l'adherence d'un adhesif a la surface d'un tissu dur
LU86172A1 (fr) Composition aqueuse de cromoglycate de sodium
JP5297815B2 (ja) 医薬組成物
LU86484A1 (fr) Sels de furosemide
EP0163582A2 (fr) Médicaments favorisant les propriétés d'écoulement du sang et leur utilisation en thérapeutique
BE898356A (fr) Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine.
US20200181136A1 (en) Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
JP4063341B2 (ja) 緑内障治療剤及び眼圧降下剤
FR2631037A1 (fr) Compositions adhesives a base d'ester phosphorique
HU179989B (en) Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration
CA2486571C (en) Pharmaceutical composition
JP2003261449A (ja) ファモチジン含有水性注射剤およびその製造法
EP4159195A1 (fr) Composition pharmaceutique topique sous forme de gel comprenant au moins de l'amitriptyline pour son utilisation dans le traitement des douleurs neuropathiques induites par un coronavirus
BE1001704A3 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
FI96742B (fi) Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi
DK155144B (da) Fremgangsmaade til fremstilling af stabile oploesninger af en blanding af hydrogenerede ergotalkaloider og heparin
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
FR3108841A1 (fr) Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
WO2011027365A9 (en) Ophthalmic compositions containing dorzolamide, timolol and brimonidine
EP2066301B1 (en) Injectable pharmaceutical nimesulide solutions

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19951231